Literature DB >> 7803798

A mutation located at the 5' splice junction sequence of intron 3 in the p67phox gene causes the lack of p67phox mRNA in a patient with chronic granulomatous disease.

L C Tanugi-Cholley1, J P Issartel, J Lunardi, F Freycon, F Morel, P V Vignais.   

Abstract

Chronic granulomatous disease (CGD) is due to a functional defect of the O2(-)-generating NADPH oxidase of neutrophils. Mutations resulting in CGD have been shown to occur in only four genes, thus identifying the main components of the oxidase complex, namely the two subunits of a membrane-bound cytochrome b and two cytosolic factors of activation of 67 kD (p67phox) and 47 kD (p47phox). The present study deals with the biochemical and genetic analysis of the defect in a patient suffering from a p67phox-deficient form of CGD. The p67phox deficiency was ascertained by immunochemistry and the ability of recombinant p67phox to restore NADPH oxidase activity using a cell-free system of oxidase activation. The cellular extracts from the proband contained no p67phox protein and no p67phox mRNA when assayed by Western and Northern blot analysis. However, reverse transcription of mRNA and subsequent cDNA amplification by polymerase chain reaction using specific p67phox primers showed that trace amounts of a p67phox mRNA deleted for exon 3 were synthesized in the patient immortalized B lymphocytes. Sequence analysis of the genomic DNA showed a T-to-C transition at position +2 of intron 3. This point mutation in the consensus 5' splice site of the intron 3 was probably responsible for lack of accumulation of mRNA and also for the skipping of exon 3 detected in the few mRNA molecules that escaped cellular degradation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7803798

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  The rodent alphaA-crystallin gene: mutagenesis of a non-consensus 5'-splice site to study alternative splicing in vivo.

Authors:  R H Smulders; B P Kokke; M L Gijsen; W W de Jong
Journal:  Mol Biol Rep       Date:  1998-11       Impact factor: 2.316

2.  Genetic and mutational heterogeneity of autosomal recessive chronic granulomatous disease in Tunisia.

Authors:  R El Kares; M R Barbouche; H Elloumi-Zghal; M Bejaoui; J Chemli; F Mellouli; N Tebib; M S Abdelmoula; S Boukthir; Z Fitouri; S M'Rad; K Bouslama; H Touiri; S Abdelhak; M K Dellagi
Journal:  J Hum Genet       Date:  2006-08-26       Impact factor: 3.172

3.  A Founder Effect of c.257 + 2T > C Mutation in NCF2 Gene Underlies Severe Chronic Granulomatous Disease in Eleven Patients.

Authors:  Khaoula Ben-Farhat; Imen Ben-Mustapha; Meriem Ben-Ali; Karen Rouault; Saber Hamami; Najla Mekki; Amel Ben-Chehida; Beya Larguèche; Zohra Fitouri; Selim Abdelmoula; Monia Khemiri; Mohamed-Neji Guediche; Samir Boukthir; Sihem Barsaoui; Jalel Chemli; Mohamed-Ridha Barbouche
Journal:  J Clin Immunol       Date:  2016-05-25       Impact factor: 8.317

Review 4.  Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update).

Authors:  Dirk Roos; Douglas B Kuhns; Anne Maddalena; Jacinta Bustamante; Caroline Kannengiesser; Martin de Boer; Karin van Leeuwen; M Yavuz Köker; Baruch Wolach; Joachim Roesler; Harry L Malech; Steven M Holland; John I Gallin; Marie-José Stasia
Journal:  Blood Cells Mol Dis       Date:  2010-02-18       Impact factor: 3.039

5.  Disturbed interaction of p21-rac with mutated p67-phox causes chronic granulomatous disease.

Authors:  J H Leusen; A de Klein; P M Hilarius; A Ahlin; J Palmblad; C I Smith; D Diekmann; A Hall; A J Verhoeven; D Roos
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

Review 6.  Lessons from Genetic Studies of Primary Immunodeficiencies in a Highly Consanguineous Population.

Authors:  Mohamed-Ridha Barbouche; Najla Mekki; Meriem Ben-Ali; Imen Ben-Mustapha
Journal:  Front Immunol       Date:  2017-06-27       Impact factor: 7.561

Review 7.  Genetics and immunopathology of chronic granulomatous disease.

Authors:  Marie José Stasia; Xing Jun Li
Journal:  Semin Immunopathol       Date:  2008-05-29       Impact factor: 11.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.